Status:
UNKNOWN
Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and Asthma
Lead Sponsor:
Lithuanian University of Health Sciences
Collaborating Sponsors:
Research Council of Lithuania
Conditions:
Atopic Dermatitis
Asthma
Eligibility:
All Genders
Up to 60 years
Brief Summary
The role of vitamin D is well known in calcium and phosphate homeostasis; however, in addition to traditional functions, vitamin D has an important role in pathogenesis of different allergic diseases,...
Eligibility Criteria
Inclusion
- Patients with mild to moderate asthma
- Patients with mild to moderate atopic dermatitis
- Healthy individuals
Exclusion
- Acute or chronic infections
- Oncological diseases
- Acute systemic autoimmune diseases
- Use of systemic immunosuppressants (wait 1 month)
- Use of vitamin D supplementation
- Use of systemic antihistamines (wait 1 week)
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04354207
Start Date
January 1 2020
End Date
December 31 2022
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, Lithuania